Navigation Links
EntreMed Reports Third Quarter 2007 Financial Results
Date:11/6/2007

ROCKVILLE, Md., Nov. 6 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today reported results for the three and nine-month periods ending September 30, 2007.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

Revenues for the third quarter 2007 were approximately $3,520,000 versus $3,023,000 for the comparable period a year ago. The Company reported a net loss for the third quarter of approximately ($3.0 million), or ($0.04) per share. This compares with a net loss of approximately ($3.5 million), or ($0.05) per share for the same period last year.

Revenues for the nine months ending September 30, 2007 were approximately $3,520,000 versus $3,023,000 for 2006. Reported net loss for the first nine months of 2007 was ($18.6 million), or ($0.23) per share as compared to ($44.3 million) or ($0.63) per share for 2006. The 2006 nine-month net loss includes a non-cash charge of $29.5 million resulting from the acquisition of Miikana Therapeutics in January 2006. Excluding the non-cash charge, the Company's net loss for the first nine months of 2006 was ($14.8 million). As of September 30, 2007, EntreMed had cash and short-term investments of approximately $50.6 million.

Dane R. Saglio, EntreMed Chief Financial Officer, commented, "Royalty revenues recorded in the third quarter 2007 represent an increase over the same period last year as we continue to benefit from the increase in sales of Celgene's Thalomid(R). As a result of additional programs heading towards clinical development in
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. EntreMed Receives Deloitte Technology Fast 50 Award
2. EntreMed to Present at the Bio 2007 Investor Forum
3. EntreMed Presents Results for Panzem(R) NCD Phase 2 Ovarian Cancer Study
4. EntreMed to Present at the Rodman and Renshaw 9th Annual Healthcare Conference
5. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
6. Haemacure Reports Third Quarter 2007 Results
7. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
8. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
9. MDS Reports Third Quarter 2007 Results
10. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
11. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...ces in mood despite similar weight loss , ...-fat, low-carbohydrate diet such as the popular At...to help people lose pounds over the course of a ye...will result in long-term improvement in mood, acco...of Internal Medicine . , People on both diets c...
(Date:11/9/2009)... may be too late when it comes to preventing or im...ub, Inc. (Take Off Pounds Sensibly), the nonprofit... (Vocus) November 9, 2009 -- Tomorrow m...oving a diabetes condition, according to TOPS Club...eight-loss support organization., , ,Diabetes is a...
(Date:11/9/2009)...wswire/ -- Health Connect Partners, Inc., ( www.h...augural Hospital O.R. and Surgery Center Conferenc...ce Hotel in Nashville, Tenn. ,, Health Connect ...ting room directors and managers from some of the ...y. Some of the confirmed providers include HCA, Bo...
(Date:11/9/2009)...nt from incapacitated to working again, , ...al stimulation of a certain area of the brain may ..., say German researchers. , They implanted elec... of 10 people. This area of the brain is part of ...r good experiences and puts them in a state of ple...
(Date:11/9/2009)...Newswire/ -- Abt Associates continues to broaden...gency management consulting and support services w...e work of the Federal Emergency Management Agency,...al Commission on Children and Disasters and the Wa...A). The value of the combined contracts is approx...
Breaking Medicine News(10 mins):Health News:To Feel Better, Low-Fat Diet May Be Best 2Health News:To Feel Better, Low-Fat Diet May Be Best 3Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:Health Connect Partners Hosts Hospital O.R. & Surgery Center Conference 2Health News:Brain Stimulation May Ease Treatment-Resistant Depression 2Health News:Abt Associates Expands Emergency Management Support Services To the Federal Government and Washington Metropolitan Area Transit Authority 2
...estern University chemists have been shown to be e...nst cerebral palsy, a condition caused by neurodeg...ordination. , "The results were just stunning, ab...the drug development effort. "There was a remarkab...
...oot causes of defects on the production , line , ...ments, whose assembly manufacturing quality system... and analyze manufacturing defects as they occur, ...company. , To achieve this status, Sciemetric unde...
... intergenerational program developed by OASIS to e...obesity will be expanded to eight cities during th...llPoint Foundation, Inc. , , Active Generations p...l settings using teams of volunteers age 50 and ol...
...wire-Asia-FirstCall/ -- China Sky One,Medical, Inc...aq: CSKI ), a,leading fully integrated pharmaceu...the People,s Republic of China ("PRC"), today,anno...South Korea and Sudan. As a result, the product is...
...ompany,s Network of International Subsidiaries and...sure, Inc. (Nasdaq: CYNO ), a leading developer...aesthetic treatment systems, today announced the a... European countries, Japan, China and Korea, and f...
...ting, lawn mowing could spell trouble , , ... suggests it,s possible that too much work might t...archers found that fifth-graders who worked the mo...k directly leads to trouble, but they raise questi...
Other Medicine News:Health News:Stunning finding: Compounds protect against cerebral palsy 2Health News:Stunning finding: Compounds protect against cerebral palsy 3Health News:Stunning finding: Compounds protect against cerebral palsy 4Health News:Sciemetric makes the grade with major medical device manufacturer 2Health News:WellPoint Foundation Awards Grants to OASIS to Expand Unique Active Generations Program 2Health News:WellPoint Foundation Awards Grants to OASIS to Expand Unique Active Generations Program 3Health News:China Sky One Medical, Inc. Exports Sumei Slim Patch to South Korea and Sudan 2Health News:China Sky One Medical, Inc. Exports Sumei Slim Patch to South Korea and Sudan 3Health News:Cynosure Appoints William T. Kelley as Senior Vice President of International Sales 2Health News:Cynosure Appoints William T. Kelley as Senior Vice President of International Sales 3Health News:Work May Not Be Best for Young Kids 2
(Date:11/9/2009)... , PHILADELPHIA, Nov. 9 /PRNewswire-FirstCall...e global specialty biopharmaceutical company, toda...uanfacine) Extended Release Tablets in pharmacies ...ntion-Deficit/Hyperactivity Disorder ( ADHD ) in...a once-daily formulation of guanfacine, is the fir...
(Date:11/9/2009)... , BETHESDA, Md., Nov. 9 /PRNewswire-Asia...aq: CHDX ), a leading independent American provid...the People,s Republic of China, today,announced re...cal 2010, which,ended September 30, 2009. , , ... quarter of fiscal 2010 was $38.1 million, flat on...
(Date:11/9/2009)... , SOUTH SAN FRANCISCO, Calif., Nov. 9 /PRNew... today announced that on November 5, 2009, it rece...asdaq") stating that the Nasdaq Hearing Panel has ... The NASDAQ Global Market subject to the condition...cember 31, 2009, the proposed merger (the "Merger"...
Breaking Medicine Technology:Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 2Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 3Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 4Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 5Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 6Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 7Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 2Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 3Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 4Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 5Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 6Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 7Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 8Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 9Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 10Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 11Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 2Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 3Blood Sugar Spikes Send Testosterone Levels Down 48816 1Blood Sugar Spikes Send Testosterone Levels Down 48816 2Siemens Makes Innovation Accessible with Comprehensive Molecular Imaging Solutions 48814 1Siemens Makes Innovation Accessible with Comprehensive Molecular Imaging Solutions 48814 2Siemens Makes Innovation Accessible with Comprehensive Molecular Imaging Solutions 48814 3Siemens Makes Innovation Accessible with Comprehensive Molecular Imaging Solutions 48814 4Clinical Study Demonstrates Superior Bioavailability of Jarrow 26apos 3Bs Proprietary QH absorb Formula 48812 1Clinical Study Demonstrates Superior Bioavailability of Jarrow 26apos 3Bs Proprietary QH absorb Formula 48812 2Clinical Study Demonstrates Superior Bioavailability of Jarrow 26apos 3Bs Proprietary QH absorb Formula 48812 3Clinical Study Demonstrates Superior Bioavailability of Jarrow 26apos 3Bs Proprietary QH absorb Formula 48812 4
...Intercell AG (VSE: ICLL) today,announced the execu...rtment of,Health and Human Services (HHS). The ag...or Intercell,s Pandemic Influenza program. , ...ine Patch System that,includes an immunostimulant ...,Pandemic Influenza vaccine (manufactured by Solva...
...Vascular BioTherapeutics, Inc. (OTC Bulletin Board...als in the United States opened for patient enroll... treatment of severe coronary heart disease. The s... Minneapolis MN, and Princeton Baptist Medical Cen...irfield (Ohio) and The Christ Hospital in Cincinna...
Other Medicine Technology:USD 12.5 m Funding for the Development of Intercell's Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS) 2USD 12.5 m Funding for the Development of Intercell's Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS) 3CVBT Opens Two Additional Sites for Patient Enrollment for Phase II Heart Trial 2
Wide Angle Twin MagNP Direct Ophthalmoscope
... the ultimate CT solution for cardiovascular and w... fastest multislice technology with dedicated clin...uality. It provides the highest performance, in or...ovascular diagnosis by utilizing innovative workfl...
...ceiling height, arm reach, power, cabling and the ...ity accommodates more gas, electric and communicat...nough for every surgical procedure and for emergen...lities, Teletoms are surprisingly easy to maneuver...
...fers you a complete solution to surgical lighting....b's original illumination to the surgical field an... field is clear and color correct with a 31" depth... 4500 Kelvin, giving you accurate tissue rendition...
Medicine Products: